Article

PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to benefit from panitumumab treatment

2024-12-19

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Practice guidelines recommend using panitumumab in combination with chemotherapy to treat KRAS wild-type (WT) metastatic colorectal cancer (mCRC) patients where it was shown to significantly extend progression-free survival (PFS) and overall survival (OS). Still, a proportion of patients will not achieve this goal. We propose a simplified predictive score to identify patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 743d67f0-3b4b-5a6e-91c2-3896d846b0b9
DOI: 10.1101/2024.12.18.24319211

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to benefit from panitumumab treatmentDOI 10.1101/2024.12.18.24319211Read

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerSemantic proximity Read

First-line treatment efficacy and prognostic model in RAS-mutant metastatic colorectal cancer: a real-world study.Semantic proximity Read

Predicting Optimal Colorectal Cancer Treatments Across Age Groups Using Machine LearningSemantic proximity Read

Age-Stratified Prediction of Optimal Colorectal CancerTreatments Using Ensemble Machine LearningSemantic proximity Read

An Integrated RNA and DNA Molecular Signature for Colorectal Cancer ClassificationSemantic proximity Read

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.Semantic proximity Read

Survival stratification for colorectal cancer via multi-omics integration using an autoencoder-based modelSemantic proximity Read

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.Semantic proximity Read

SCOPE: Integrating Organoid Screening and Clinical Variables Through Machine Learning for Cancer Trial Outcome PredictionSemantic proximity Read

Personalized Risk Stratification in Colon Cancer using Radiomic-Based Predictive ModelsSemantic proximity Read

Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER databaseSemantic proximity Read

An Interpretable Machine Learning Host-Response Score for Postoperative Disease-Free Survival Risk Stratification in Colorectal Adenocarcinoma: A Retrospective Prognostic Modelling StudySemantic proximity Read